Browse by all authors Browse By Author ID - Green, Bruce

Browse Results (40 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Refine

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Duffull, SB, Kirkpatrick, CMJ, Green, B and Holford, NHG (2005) Analysis of population pharmacokinetic data using NONMEM and WinBUGS. Journal of Biopharmaceutical Statistics, 15 1: 53-73. doi:10.1081/BIP-200040824 344   33 Cited 34 times in Scopus34 0
Green, Bruce and McLeay, Sarah C. (2011) Anesthetizing the obese. Anesthesia and Analgesia, 113 1: 1-3. doi:10.1213/ANE.0b013e318212eae8 41   4 Cited 5 times in Scopus5 0
Lack, N., Green, B., Dale, D., Calandra, G., Lee, H., MacFarland, R., Badel, K., Liles, W. C. and Bridger, G. (2005) A Pharmacokinetic-Pharmacodynamic model for the mobilization of CD34+ hematopoietic progenitor cells by AMD3100. Clinical Pharmacology and Therapeutics, 77 5: 427-436. doi:10.1016/j.clpt.2004.12.268 131   43 Cited 46 times in Scopus46 0
Barras, M. A., Duffull, S., Atherton, J. and Green, B. (2007). A Population PKPD Model for Bleeding Events with Enoxaparin. In: 2007 AAPS Annual Meeting and Exposition, San Diego California, (147-147). 11th-15th November, 2007. 65  
Feng, Y., Green, B., Duffull, S. B., Kane, S. L., Bobek, M. B. and Bies, R. R. (2005). Application of Monte Carlo simulations to identify an appropriate dosage strategy for patients receiving a continuous intravenous infusion of enoxaparin. In: C. M. Stein, Clinical Pharmacology & Therapeutics. 2005 Annual Meeting of American Society for Clinical Pharmacology & Therapeutics, Orlando, USA, (P88-P88). 2-6 March 2005. doi:10.1016/j.clpt.2004.12.230 53   0 0
Duffull, SB, Dooley, MJ, Green, B, Poole, SG and Kirkpatrick, CMJ (2004) A standard weight descriptor for dose adjustment in the obese patient. Clinical Pharmacokinetics, 43 15: 1167-1178. doi:10.2165/00003088-200443150-00007 178   42 Cited 52 times in Scopus52 0
Whitty, J. A., Green, B. and Cottrell, N. (2001) A study to determine the importance of ward pharmacists reviewing discharge prescriptions. Australian Journal of Hospital Pharmacy, 31 4: 300-302. 125  
Green, B. (2002) Australia's obesity epidemic: The big picture. Pharmacy News, 2002 14 Nov.: 11-14. 187  
Green, B. (2003). Clinical simulation and optimal design. In: Annual Conference of Australasian Pharmaceutical Science Association. Annual Conference of Australasian Pharmaceutical Science Association, Bondi Beach, NSW, (43-43). 3-5 Dec.2003. 32  
Green, B. and Holford, N. H. (2005). Critical values for rejecting the null involving mixture models: Identification of poor metabolizers and non-responders. In: 2005 AAPS Annual Meeting & Exposition. 2005 AAPS Annual Meeting & Exposition, Nashville, TN, (W5320). 6-10 Nov. 2005. 49  
Barras, Michael A., Kirkpatrick, Carl M.J. and Green, Bruce (2010) Current dosing of low-molecular-weight heparins does not reflect licensed product labels: An international survey. British Journal of Clinical Pharmacology, 69 5: 520-528. doi:10.1111/j.1365-2125.2010.03626.x 102   1 Cited 6 times in Scopus6 0
Feng, Y, Green, B, Duffull, SB, Kane-Gill, SL, Bobek, MB and Bies, RR (2006) Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulation. British Journal of Clinical Pharmacology, 62 2: 165-176. doi:10.1111/j.1365-2125.2006.02650.x 52   10 Cited 10 times in Scopus10 0
Green, Bruce and Duffull, Stephen B. (2003) Development of a dosing strategy for enoxaparin in obese patients. British Journal of Clinical Pharmacology, 56 1: 96-103. doi:10.1046/j.1365-2125.2003.01849.x 415   45 Cited 56 times in Scopus56 0
Green, B., Atherton, J. J., Westhuyzen, J., Kluver, L. and Saltisi, D. (2003). Development of a dosing strategy for enoxaparin in patients with renal impairment using a population pharmacokinetic approach. In: Conference Proceedings of Population Approach Group in Europe. Conference Proceedings of Population Approach Group in Europe3, Verona, Italy, (394-394). 12-13 June 2003. 66  
Green, B (2006). Development of a novel hematopoietic cell mobilize using a model-based approach. In: Proceedings of the Australian Health and Medical ResearchCongress 2006. The Australian Health & Medical Research Congress, Melbourne / Melbourne Convention Centre, (129-129). 26 November-1 December 2006. 28  
Millican, S, Cottrell, N and Green, B (2004) Do risk factors for lactic acidosis influence dosing of metformin?. Journal of Clinical Pharmacy And Therapeutics, 29 5: 449-454. doi:10.1111/j.1365-2710.2004.00589.x 152   8 Cited 14 times in Scopus14 0
Han, P. Y., Duffull, S. B., Kirkpatrick, C. M. J. and Green, B. (2007) Dosing in obesity: A simple solution to a big problem. Clinical Pharmacology & Therapeutics, 82 5: 505-508. doi:10.1038/sj.clpt.2007.6100381 112   79 Cited 91 times in Scopus91 0
Green, Bruce. (2002). Dosing of enoxaparin in obese patients PhD Thesis, School of Pharmacy, The University of Queensland. 421 3
Green, B., Greenwood, M., Saltisi, D., Westhuyzen, J., Kluver, L., Rowell, J. and Atherton, J. (2005) Dosing Strategy for Enoxaparin in Patients with Renal Impairment Presenting with Acute Coronary Syndromes. British Journal of Clinical Pharmacology, 59 3: 281-290. doi:10.1111/j.1365-2125.2004.02253.x 190   36 Cited 47 times in Scopus47 0
McLeay, Sarah C., Morrish, Glynn A., Kirkpatrick, Carl M. and Green, Bruce (2009) Encouraging the move towards predictive population models for the obese using propofol as a motivating example. Pharmaceutical Research, 26 7: 1626-1634. doi:10.1007/s11095-009-9873-7 56   15 Cited 19 times in Scopus19 0
Han, PY, Coombes, ID and Green, B (2005) Factors predictive of intravenous fluid administration errors in Australian surgical care wards. Quality & Safety In Health Care, 14 3: 179-184. doi:10.1136/qshc.2004.010728 177   23 Cited 31 times in Scopus31 0
White, S. and Green, B. (2000) Gastro-oesophageal reflux disease: The burning issues. Australian Pharmacist, 19 11: 682-687. 36  
Green, B. (2002) Hypertension: Is there anything new?. Pharmacy News, 2002 16 May: 11-15. 54  
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008) Individualized compared with conventional dosing of enoxaparin. Clinical Pharmacology & Therapeutics, 83 6: 882-888. doi:10.1038/sj.clpt.6100399 83   16 Cited 24 times in Scopus24 0
Barras, Michael A., Duffull, Stephen B., Atherton, John J. and Green, Bruce (2010) Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations. Therapeutic Drug Monitoring, 32 4: 482-488. doi:10.1097/FTD.0b013e3181e64846 79   4 Cited 6 times in Scopus6 0
Green, B (2006). Introduction to population PK/PD. In: Andrew Davey, Perspectives on the use of medicines: The individual vs the population. Annual Conference of the Australasian Pharmaceutical Science n, Adelaide / Adelaide Hilton, (19-19). 3-5 December 2006. 92  
Janmahasatian, S., Duffull, S. B., Chagnac, A., Kirkpatrick, C. M.J. and Green, B. (2008) Lean body mass normalizes the effect of obesity on renal function. British Journal of Clinical Pharmacology, 65 6: 964-965. doi:10.1111/j.1365-2125.2008.03112.x 62   27 Cited 30 times in Scopus30 1
McLeay, S., Morrish, G., Kirkpatrick, C. and Green, B. (2007). Lean bodyweight as a descriptor for propofol clearance. In: 2007 AAPS Annual Meeting and Exposition, San Diego, CA, U.S.A., (147-147). 11-15 November 2007. 62  
McLeay, Sarah, Morrish, Glynn, Kirkpatrick, Carl and Green, Bruce (2008). Lean body weight versus total body weight for propofol dosing. In: PAGE. Abstracts of the Annual Meeting of the Population Approach Group in Europe. PAGE PAGANZ 08 (2008), Dunedin, New Zealand, (). 13-15 February 2008. 191  
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2009) Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events. British Journal of Clinical Pharmacology, 68 5: 700-711. doi:10.1111/j.1365-2125.2009.03518.x 82   8 Cited 11 times in Scopus11 0
Green, B, Duffull, S, Cottrell, N and D'Emden, M (2002) Myocardial infarction and type II diabetes - preferential treatment for high risk patients?. Journal of Clinical Pharmacy And Therapeutics, 27 5: 371-376. doi:10.1046/j.1365-2710.2002.00436.x 58   0 Cited 2 times in Scopus2 0
Green, B., Cairns, S., Harvey, R. and Pettit, M. (2000) Phytomenadione or menadiol in the management of an elevated international normalized ratio (prothrombin time). Alimentary Pharmacology & Therapeutics, 14 12: 1685-1689. doi:10.1046/j.1365-2036.2000.00880.x 50   4 Cited 3 times in Scopus3 0
Green, B and Duffull, SB (2003) Prospective evaluation of a D-optimal designed population pharmacokinetic study. Journal of Pharmacokinetics And Pharmacodynamics, 30 2: 145-161. doi:10.1023/A:1024467714170 53   39 Cited 42 times in Scopus42 0
Janmahasatian, S, Duffull, SB, Ash, S, Ward, LC, Byrne, NM and Green, B (2005) Quantification of lean bodyweight. Clinical Pharmacokinetics, 44 10: 1051-1065. doi:10.2165/00003088-200544100-00004 151   177 Cited 193 times in Scopus193 0
Han, P., Kirkpatrick, C., Duffull, S. and Green, B. (2007). The effect of study design on identifying true covariate relationships. In: 2007 AAPS Annual Meeting and Exposition, San Diego, CA, U.S.A., (149-149). 11-15 November 2007. 36  
Hanze, E., Green, B, Duffull, S B, Doogue, M., Begg, E and Kirkpatrick, C M J (2006). The influence of metformin on Hba1c: A PKPD model. In: Proceedings of the 2006 AAPS Annual Meeting and Exposition. 2006 AAPS Annual Meeting and Exposition, Henry B. Gonzalez Convention Center, San Antonio, TX, (). October 29-November 2, 2006. 157  
McLeay, Sarah, Morrish, Glynn, Kirkpatrick, Carl and Green, Bruce (2009). The population pharmacokinetics of propofol: a meta-analysis of studies available from the OpenTCI Initiative. In: PAGE. Abstracts of the Annual Meeting of the Population Approach Group in Europe. 18th Meeting of Population Approach Group in Europe (PAGE), St. Petersburg, Russia, (). 23-26 June 2009. 158  
McLeay, Sarah C., Morrish, Glynn A., Kirkpatrick, Carl M. J. and Green, Bruce (2012) The relationship between drug clearance and body size: systematic review and meta-analysis of the literature published from 2000 to 2007. Clinical Pharmacokinetics, 51 5: 319-330. doi:10.2165/11598930-000000000-00000 59   26 Cited 22 times in Scopus22 0
Green, B. and Duffull, S. B. (2004) What is the best size descriptor to use for pharmacokinetic studies in the obese?. British Journal of Clinical Pharmacology, 58 2: 119-133. doi:10.1111/j.1365-2125.2004.02157.x 68   109 Cited 133 times in Scopus133 0
Paddon, K. and Green, B. (2004) Which patients are prescribed COX-2 inhibitors rather than nonspecific anti-inflammatory drugs?. Australian Family Physician, 33 6: 475-476. 34 1 Cited 0 times in Scopus0